Your browser doesn't support javascript.
loading
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas.
De Bacco, Francesca; Orzan, Francesca; Crisafulli, Giovanni; Prelli, Marta; Isella, Claudio; Casanova, Elena; Albano, Raffaella; Reato, Gigliola; Erriquez, Jessica; D'Ambrosio, Antonio; Panero, Mara; Dall'Aglio, Carmine; Casorzo, Laura; Cominelli, Manuela; Pagani, Francesca; Melcarne, Antonio; Zeppa, Pietro; Altieri, Roberto; Morra, Isabella; Cassoni, Paola; Garbossa, Diego; Cassisa, Anna; Bartolini, Alice; Pellegatta, Serena; Comoglio, Paolo M; Finocchiaro, Gaetano; Poliani, Pietro L; Boccaccio, Carla.
Afiliação
  • De Bacco F; Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy; Department of Oncology, University of Turin, 10060 Candiolo, Italy.
  • Orzan F; Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Crisafulli G; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
  • Prelli M; Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy; Department of Oncology, University of Turin, 10060 Candiolo, Italy.
  • Isella C; Department of Oncology, University of Turin, 10060 Candiolo, Italy; Laboratory of Oncogenomics, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Casanova E; Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Albano R; Core Facilities, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Reato G; Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy; Department of Oncology, University of Turin, 10060 Candiolo, Italy.
  • Erriquez J; Core Facilities, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • D'Ambrosio A; Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Panero M; Unit of Pathology, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Dall'Aglio C; Unit of Pathology, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Casorzo L; Unit of Pathology, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Cominelli M; Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
  • Pagani F; Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
  • Melcarne A; Neurosurgery Unit, Città della Salute e della Scienza University Hospital, 10126 Turin, Italy.
  • Zeppa P; Neurosurgery Unit, Città della Salute e della Scienza University Hospital, 10126 Turin, Italy; Department of Neurosciences, University of Turin, 10126 Turin, Italy.
  • Altieri R; Department of Neurosciences, University of Turin, 10126 Turin, Italy.
  • Morra I; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Cassoni P; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Garbossa D; Neurosurgery Unit, Città della Salute e della Scienza University Hospital, 10126 Turin, Italy; Department of Neurosciences, University of Turin, 10126 Turin, Italy.
  • Cassisa A; Laboratory of Oncogenomics, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Bartolini A; Core Facilities, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Pellegatta S; Unit of Immunotherapy of Brain Tumors, Fondazione IRCCS Istituto Neurologico C. Besta, 20133 Milan, Italy.
  • Comoglio PM; IFOM ETS - The AIRC Institute of Molecular Oncology, 20139 Milan, Italy.
  • Finocchiaro G; Department of Neurology, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
  • Poliani PL; Pathology Unit, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
  • Boccaccio C; Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy; Department of Oncology, University of Turin, 10060 Candiolo, Italy. Electronic address: carla.boccaccio@ircc.it.
Cell Rep ; 42(8): 112816, 2023 08 29.
Article em En | MEDLINE | ID: mdl-37505981
ABSTRACT
Glioblastoma (GBM) is known as an intractable, highly heterogeneous tumor encompassing multiple subclones, each supported by a distinct glioblastoma stem cell (GSC). The contribution of GSC genetic and transcriptional heterogeneity to tumor subclonal properties is debated. In this study, we describe the systematic derivation, propagation, and characterization of multiple distinct GSCs from single, treatment-naive GBMs (GSC families). The tumorigenic potential of each GSC better correlates with its transcriptional profile than its genetic make-up, with classical GSCs being inherently more aggressive and mesenchymal more dependent on exogenous growth factors across multiple GBMs. These GSCs can segregate and recapitulate different histopathological aspects of the same GBM, as shown in a paradigmatic tumor with two histopathologically distinct components, including a conventional GBM and a more aggressive primitive neuronal component. This study provides a resource for investigating how GSCs with distinct genetic and/or phenotypic features contribute to individual GBM heterogeneity and malignant escalation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália